News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Existing biomarkers predicting ICI treatment response in advanced NSCLC
Mehrdad Rakaee/LinkedIn
Dec 29, 2024, 10:21

Existing biomarkers predicting ICI treatment response in advanced NSCLC

JAMA Oncology shared a post on X:

“A deep learning AI model showed improved accuracy over existing biomarkers in predicting immune checkpoint inhibitor treatment response in advanced non-small cell lung cancer patients.”

biomarkers

Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer

Authors: Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao V. Alessi, Alessio Cortellini, Fabrizio Citarella, Lorenzo Nibid, Giuseppe Perrone, Elio Adib, Claudia A. M. Fulgenzi, Cassio Murilo Hidalgo Filho, Alessandro Di Federico, Falah Jabar, Sayed Hashemi, Ilias Houda, Elin Richardsen, Lill-Tove Rasmussen Busund, Tom Donnem, Idris Bahce, David J. Pinato, Åslaug Helland, Lynette M. Sholl, Mark M. Awad, and David J. Kwiatkowski.

biomarkers

AI Alessandro Di Federico Alessio Cortellini Åslaug Helland Biagio Ricciuti cancer Cassio Murilo Hidalgo Filho Claudia A. M. Fulgenzi David J. Kwiatkowski David J. Pinato Elin Richardsen Elio Adib Fabrizio Citarella Falah Jabar Giuseppe Perrone ICI treatment Idris Bahce Ilias Houda JAMA Oncology Joao V. Alessi Lill-Tove Rasmussen Busund Lorenzo Nibid Lynette M. Sholl Mark M. Awad Masoud Tafavvoghi Mehrdad Rakaee non small cell lung cancer NSCLC OncoDaily Oncology Sayed Hashemi Tom Donnem
Special Coverage
Voices
Sep 4, 2025, 09:26
Kevin Lo: A Touch of Pink for a Powerful Purpose
Science
Sep 4, 2025, 09:19
Elisa De Paolis: NRG1 VUS Network Analysis and Prognostic Role in EGFR-Mutant NSCLC
FDA Approvals
Sep 4, 2025, 09:08
FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC
Voices
Sep 4, 2025, 09:05
What Problems We’re Addressing and How We’re Supporting Children with Cancer - World Child Cancer USA
Insight
Sep 4, 2025, 08:53
Register Now for ASGCR 2025 Select Sessions - NCI Center for Global Health
Voices
Sep 4, 2025, 08:49
Rob Winn: Ovarian Cancer Awareness Month - Raising Awareness to Change the Future
Voices
Sep 4, 2025, 08:36
Zainab Shinkafi-Bagudu: Delivering Cancer Education at NISS Health Week
Voices
Sep 4, 2025, 08:36
Thoracic Circle is Live! - IASLC
Voices
Sep 4, 2025, 08:27
Breast Cancer Treatment in Low-resource Countries - The Max Foundation
Insight
Sep 4, 2025, 08:13
Society for Integrative Oncology Released New Integrative Oncology eBook
Science
Sep 4, 2025, 08:13
Neil Iyengar: New Report on GLP1 Receptor Agonist Use in Breast Cancer Survivors
Career Updates
Sep 4, 2025, 08:02
Gail Garvey Has Received the 2025 Tom Reeve Award for Outstanding Contribution to Cancer Care - COSA